Narrow search
Showing 1 - 10 of 5,753
Cover Image
Die Rolle des Staates in der Impfstoffproduktion: Technologische Restriktionen und ökonomische Ableitungen
Kirchhoff, Jasmina - 2021
Die Bundesregierung und die Europäische Kommission mussten in den letzten Wochen viel Kritik bezüglich ihrer Impfstoffbeschaffungsstrategie zur Eindämmung der Corona-Pandemie einstecken. Vor dem Hintergrund zu schleppend erscheinender Impfstofflieferungen und der zunehmenden Gefahr durch die...
Persistent link: https://www.econbiz.de/10012439017
Cover Image
Die Rolle der chemisch-pharmazeutischen Industrie im Gesundheitswesen
Rosenbrock, Rolf - In: Vernachlässigte Gesundheit: zum Verhältnis von …, (pp. 222-256). 1980
Persistent link: https://www.econbiz.de/10011292202
Cover Image
The EU Health Union in Search of a Definition and an Open Discussion
Sipiczki, Agnes; Lannoo, Karel - In: Intereconomics 56 (2021) 3, pp. 150-152
More than other EU 'Unions', the proposed Health Union requires proper definition because the EU's competences are limited in this domain.
Persistent link: https://www.econbiz.de/10012700511
Cover Image
Der Effekt von Parallelhandel auf die regulierten Medikamentenpreise
Weder, Rolf; Schläpfer, Alain - 2009
Die Frage der Zulassung von Parallelimporten von patentierten Gütern wird in der Schweiz kontrovers diskutiert. Medikamente stellen dabei einen Spezialfall der Güter mit Patentschutz dar, da die Preise für Medikamente in allen westlichen Ländern durch staatliche Behörden direkt oder...
Persistent link: https://www.econbiz.de/10011428801
Cover Image
Competition law and access to medicines: Lessons from Brazilian regulation and practice
Falcão, Matheus Z.; Gondo, Mariana; Navarrete, Ana Carolina - 2022
Competition law may play an important role in drug pricing control by containing high prices derived from economic violations. Since the use of competition tools is not limited by the TRIPS Agreement or other international binding disciplines, there is ample policy room to explore how countries,...
Persistent link: https://www.econbiz.de/10013330841
Cover Image
Determinants of pharmaceutical innovation: The role of technological opportunities revisited
Rake, Bastian - 2012
pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry's R&D activities … number of new pharmaceuticals in the United States. Technological opportunities are operationalized as growth rates of the …-maximum likelihood estimator. The results reveal a rather robust and significantly positive response of the number of new pharmaceuticals …
Persistent link: https://www.econbiz.de/10010291820
Cover Image
Primat der Prävention
Rosenbrock, Rolf - In: Der Arzneimittelbrief: unabhängiges Informationsblatt … 27 (1993) 7, pp. 49-50
Persistent link: https://www.econbiz.de/10011384942
Cover Image
The imperative of international cooperation for EU competitiveness and resilience in technology-driven industries
Bauer, Matthias; Zilli, Renata; Pandya, Dyuti - 2023
efficiency in technology-intensive industries. Various sectors, including pharmaceuticals, ICT, aerospace, and defence, heavily …
Persistent link: https://www.econbiz.de/10014560202
Cover Image
R&D in the Belgian Pharmaceutical Sector
De Doncker, Helga - 2006
The Belgian pharmaceutical sector has been accorded a leading role in the attainment of the R&D investment targets which the EU Member States set themselves as part of the Lisbon strategy. To gain a better insight into that sector’s research activities, the NBB conducted an ad hoc survey in...
Persistent link: https://www.econbiz.de/10011506627